Gavin is GM of Arysana, a biopharma specialist software innovator, which develops digital solutions for biopharma evidence generation and dissemination workflows, helping get healthcare interventions to patients faster and more efficiently. Gavin began his biopharma sector career in 2003 as a change manager in Pfizer R&D, has held global leadership roles in biopharma services companies Kinapse and Aesara, and started his working life as an officer in the UK’s Royal Air Force. Gavin holds an MA in English from Oxford University.
Researchers estimate that AI could generate up to $100 billion annually across the healthcare sector by optimizing clinical trials, streamlining administrative processes, and improving diagnosis accuracy. Yet, despite the promise, scaling AI beyond pilot projects and into widespread adoption remains a significant challenge. From data silos and regulatory hurdles to integration with legacy systems and ethical concerns, the road to AI-driven transformation is complex. During the opening panel discussion key opinion leaders will discuss actionable solutions on how to move AI implementation from pilot projects to enterprise-wide implementation.
Key discussion points include:
Check out the incredible speaker line-up to see who will be joining Gavin.
Download The Latest Agenda